MGRX Stock Overview
Develops, markets, and sells various men’s wellness products and services through a telemedicine platform in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Mangoceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.24 |
| 52 Week High | US$2.38 |
| 52 Week Low | US$0.14 |
| Beta | 0 |
| 1 Month Change | -18.03% |
| 3 Month Change | 8.75% |
| 1 Year Change | -80.08% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -93.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| MGRX | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | -6.7% | 3.1% | 1.7% |
| 1Y | -80.1% | 25.0% | 26.3% |
Return vs Industry: MGRX underperformed the US Consumer Retailing industry which returned 24.8% over the past year.
Return vs Market: MGRX underperformed the US Market which returned 26.3% over the past year.
Price Volatility
| MGRX volatility | |
|---|---|
| MGRX Average Weekly Movement | 15.0% |
| Consumer Retailing Industry Average Movement | 5.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: MGRX's share price has been volatile over the past 3 months.
Volatility Over Time: MGRX's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 3 | Jacob Cohen | www.mangoceuticals.com |
Mangoceuticals, Inc. develops, markets, and sells various men’s wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.
Mangoceuticals, Inc. Fundamentals Summary
| MGRX fundamental statistics | |
|---|---|
| Market cap | US$5.78m |
| Earnings (TTM) | -US$9.02m |
| Revenue (TTM) | US$844.87k |
6.8x
P/S Ratio-0.6x
P/E RatioIs MGRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MGRX income statement (TTM) | |
|---|---|
| Revenue | US$844.87k |
| Cost of Revenue | US$323.17k |
| Gross Profit | US$521.70k |
| Other Expenses | US$9.54m |
| Earnings | -US$9.02m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.38 |
| Gross Margin | 61.75% |
| Net Profit Margin | -1,067.52% |
| Debt/Equity Ratio | -9.1% |
How did MGRX perform over the long term?
See historical performance and comparison